BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Interim Analysis Supports Continuation Of Allos Therapeutics, Inc.'s Pivotal Phase 3 Trial

  April 4, 2006

   · 

  6 min read
• Policy

  US FDA Warns VaxGen Over Anthrax Vaccine Promotion

  April 4, 2006

   · 

  1 min read
• BioForest

  Seattle Genetics, Inc. Announces Closing Of Common Stock Offering

  April 4, 2006

   · 

  1 min read
• Drug Development

  Halozyme Therapeutics, Inc. Presents Preclinical And Phase I Pharmacokinetic Data For Chemophase At The 2006 American Association for Cancer Research Annual Meeting

  April 4, 2006

   · 

  5 min read
• Pharm Country

  SyntheMed, Inc. Completes $6.0 Million Equity Financing

  April 4, 2006

   · 

  2 min read
• Drug Development

  Bayhill Therapeutics, Inc. Research On Multiple Sclerosis Chosen As One Of The Meeting’s Scientific Program Highlights At The 58th Annual Meeting Of The American Academy Of Neurology

  April 4, 2006

   · 

  1 min read
• Drug Development

  ImClone Systems Incorporated Announces Favorable Outcome In Binding Arbitration Over Rights To IMC-11F8

  April 4, 2006

   · 

  1 min read
• Drug Development

  PharmaMar S.A. Highlights Aplidin(R) Results At American Association for Cancer Research

  April 4, 2006

   · 

  1 min read
• Drug Development

  CytRx Corporation Completes Enrollment In Phase IIa Clinical Trial For ALS

  April 4, 2006

   · 

  1 min read
• Drug Development

  Sepracor, Inc. Announces Publication Of LUNESTA(TM) Insomnia-Depression Study In Biological Psychiatry

  April 4, 2006

   · 

  1 min read